Affordable Access

Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery.

Authors
  • 1
Type
Published Article
Journal
The Journal of thoracic and cardiovascular surgery
1097-685X
Publication Date
Volume
131
Issue
2
Pages
352–356
Identifiers
PMID: 16434264
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments